Cargando…
Correction to: Comparing cost-utility of DMARDs in autoantibody-negative rheumatoid arthritis patients
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536788/ https://www.ncbi.nlm.nih.gov/pubmed/35362536 http://dx.doi.org/10.1093/rheumatology/keac168 |
| _version_ | 1784803054798766080 |
|---|---|
| author | Luurssen-Masurel, Nathalie Van Mulligen, Elise Weel, Angelique Elisabeth Adriana Maria Hazes, Johanna Maria Wilhelmina de Jong, Pascal Hendrik Pieter |
| author_facet | Luurssen-Masurel, Nathalie Van Mulligen, Elise Weel, Angelique Elisabeth Adriana Maria Hazes, Johanna Maria Wilhelmina de Jong, Pascal Hendrik Pieter |
| author_sort | Luurssen-Masurel, Nathalie |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9536788 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95367882022-10-07 Correction to: Comparing cost-utility of DMARDs in autoantibody-negative rheumatoid arthritis patients Luurssen-Masurel, Nathalie Van Mulligen, Elise Weel, Angelique Elisabeth Adriana Maria Hazes, Johanna Maria Wilhelmina de Jong, Pascal Hendrik Pieter Rheumatology (Oxford) Corrections Oxford University Press 2022-04-01 /pmc/articles/PMC9536788/ /pubmed/35362536 http://dx.doi.org/10.1093/rheumatology/keac168 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Rheumatology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Corrections Luurssen-Masurel, Nathalie Van Mulligen, Elise Weel, Angelique Elisabeth Adriana Maria Hazes, Johanna Maria Wilhelmina de Jong, Pascal Hendrik Pieter Correction to: Comparing cost-utility of DMARDs in autoantibody-negative rheumatoid arthritis patients |
| title | Correction to: Comparing cost-utility of DMARDs in autoantibody-negative rheumatoid arthritis patients |
| title_full | Correction to: Comparing cost-utility of DMARDs in autoantibody-negative rheumatoid arthritis patients |
| title_fullStr | Correction to: Comparing cost-utility of DMARDs in autoantibody-negative rheumatoid arthritis patients |
| title_full_unstemmed | Correction to: Comparing cost-utility of DMARDs in autoantibody-negative rheumatoid arthritis patients |
| title_short | Correction to: Comparing cost-utility of DMARDs in autoantibody-negative rheumatoid arthritis patients |
| title_sort | correction to: comparing cost-utility of dmards in autoantibody-negative rheumatoid arthritis patients |
| topic | Corrections |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536788/ https://www.ncbi.nlm.nih.gov/pubmed/35362536 http://dx.doi.org/10.1093/rheumatology/keac168 |
| work_keys_str_mv | AT luurssenmasurelnathalie correctiontocomparingcostutilityofdmardsinautoantibodynegativerheumatoidarthritispatients AT vanmulligenelise correctiontocomparingcostutilityofdmardsinautoantibodynegativerheumatoidarthritispatients AT weelangeliqueelisabethadrianamaria correctiontocomparingcostutilityofdmardsinautoantibodynegativerheumatoidarthritispatients AT hazesjohannamariawilhelmina correctiontocomparingcostutilityofdmardsinautoantibodynegativerheumatoidarthritispatients AT dejongpascalhendrikpieter correctiontocomparingcostutilityofdmardsinautoantibodynegativerheumatoidarthritispatients |